According to Cognitive Market Research, the global NK Cell Therapy market size will be USD 100.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 44.20% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 40.20 million in 2024 and will grow at a compound annual growth rate (CAGR) of 42.4% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 30.15 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 23.12 million in 2024 and will grow at a compound annual growth rate (CAGR) of 46.2% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 5.03 million in 2024 and will grow at a compound annual growth rate (CAGR) of 43.6% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 2.01 million in 2024 and will grow at a compound annual growth rate (CAGR) of 43.9% from 2024 to 2031.
The NK Cell Therapies is the fastest growing segment of the NK Cell Therapy industry
